Symphony Limited share price
NSE: SYMPHONY · ISIN INE225D01027
Key numbers
- Market cap
- ₹ 4,043 Cr
- Current price
- ₹ 588.80
- 52-week high / low
- ₹ 970 / 562
- Stock P/E
- -
- Book value
- ₹ 79.4
- Dividend yield
- 1.53%
- ROCE
- -5.3%
- ROE
- -21.6%
- Debt to equity
- 0.32
- Sales growth (3 yrs)
- -1.7%
- Profit growth (3 yrs)
- -
- 1-year return
- -35.8%
About Symphony Limited
Symphony Limited, together with its subsidiaries, manufactures and trades in air coolers and other appliances under the Symphony brand for residential, commercial, and industrial customers in India and internationally. The company offers household coolers, such as desert, room, personal, and spot; air cooler; industrial air coolers; portable cooler; commercial coolers; large space venti-cooling; tower fans; and water heaters, including spa, sauna, and soul geysers. The company was formerly known as Symphony Comfort Systems Limited and changed its name to Symphony Limited in March 2010. Symphony Limited was founded in 1939 and is based in Ahmedabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 488 | 350 | 179 | 338 | 378 |
| Operating profit | 107 | 36 | 29 | 50 | 46 |
| Net profit | 79 | 42 | 20 | -218 | 40 |
| EPS (₹) | 11.39 | 6.08 | 3.00 | -31.87 | 5.77 |
Concall summary (2026-08-11)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- So at least in the short term, we expect there to be margin pressure, although, we would be passing on some of it to the market, not all of it, because we don't know, how long this is going to last.
- So, I think we sho uldn't expect that going forward.
Growth & demand
- Symphony Limited Aug 04, 2026 Bonaire USA is now back to track and revenue grew by 35% with a robust profitability mainly on account of successful scale -up of new models of air - cooler.
- India revenue grew by 15%, despite huge inventory overhang before the summer and importantly all different segments of modern trade grew in excess of 100%, while digital channels including D2C are highly profitable, in excess of our normal domestic business and has a huge potential to scale up.
Margins & costs
- So, on a consolidated basis for June '26, revenue stands at ₹378 crore, up by 8% YoY, EBITDA stands at ₹48 crore, up from ₹38 crore, up by 26%, while Consol PAT stands at ₹40 crore, down from ₹42 crore.
- However, EBITDA and PAT, I wish to look at from the point of view of - in June '26, there has been onetime non -cash expenditure of ₹5 crore, while in June 25, there was exceptional ₹9 crore of higher income.
Capex & expansion
- The performance is led by domestic performance duly supported by gross profit margi n and EBITDA margin expansion, as shared earlier.
- This is after remitting to Australia and repaying their acquisition loan as well as working capital loan until 30th June ‘26 of approximately ₹225 crore.
Balance sheet & cash
- GSK China revenue grew by 43% and operating leverage lifted the profitability, as well as now, GSK Ch ina on a standalone basis is completely debt free and has repaid all the debt along with interest to Symphony India just like as it happened many years before with IMPCO Mexico.
- For June '26 quarter, the Board of Directors had announced interim dividend of ₹1 per share on a face value of ₹2 with a total payout of about ₹7 crore.
Peers in Furnishings, Fixtures & Appliances
Data for information only, not investment advice. Prices end of day.